Roche Holding AG (TSX:ROG)
28.70
-0.10 (-0.35%)
At close: Sep 17, 2026
Roche Holding AG Revenue
Roche Holding AG had revenue of 31.45B CHF in the half year ending June 30, 2026, with 2.26% growth. This brings the company's revenue in the last twelve months to 62.96B, down -0.83% year-over-year. In the year 2025, Roche Holding AG had annual revenue of 63.36B with 1.54% growth.
Revenue (ttm)
62.96B CHF
Revenue Growth
-0.83%
P/S Ratio
4.38
Revenue / Employee
609.78K CHF
Employees
103,249
Market Cap
485.13B CAD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 63.36B | 961.00M | 1.54% |
| Dec 31, 2024 | 62.40B | 1.95B | 3.23% |
| Dec 31, 2023 | 60.44B | -5.37B | -8.16% |
| Dec 31, 2022 | 65.81B | -36.00M | -0.05% |
| Dec 31, 2021 | 65.85B | 5.51B | 9.13% |
| Dec 31, 2020 | 60.34B | -3.41B | -5.35% |
| Dec 31, 2019 | 63.75B | 4.25B | 7.15% |
| Dec 31, 2018 | 59.50B | 3.75B | 6.73% |
| Dec 31, 2017 | 55.75B | 3.11B | 5.91% |
| Dec 31, 2016 | 52.64B | 2.23B | 4.43% |
| Dec 31, 2015 | 50.40B | 537.00M | 1.08% |
| Dec 31, 2014 | 49.87B | 1.25B | 2.58% |
| Dec 31, 2013 | 48.61B | 1.17B | 2.46% |
| Dec 31, 2012 | 47.44B | 3.33B | 7.55% |
| Dec 31, 2011 | 44.11B | -5.05B | -10.28% |
| Dec 31, 2010 | 49.17B | -1.98B | -3.88% |
| Dec 31, 2009 | 51.15B | 3.25B | 6.78% |
| Dec 31, 2008 | 47.90B | -472.00M | -0.98% |
| Dec 31, 2007 | 48.38B | 4.94B | 11.38% |
| Dec 31, 2006 | 43.43B | 6.47B | 17.52% |
| Dec 31, 2005 | 36.96B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Roche Holding AG News
- 1 day ago - Weekly Buzz: RARE, BAYRY Win Approvals; SION Cuts Jobs, GSK Deals; AZN, RHHBY Lead - Nasdaq
- 1 day ago - CHMP recommends EU approval of Roche’s Ocrevus for children and adolescents - TheFly
- 1 day ago - CHMP recommends EU approval of Roche's Ocrevus for children and adolescents with relapsing multiple sclerosis - GlobeNewsWire
- 1 day ago - Roche, Genentech Expand U.S. Research Footprint With New Boston Center - Nasdaq
- 2 days ago - Genentech and Roche Announce Grand Opening of Boston R&D Innovation Center - Business Wire
- 2 days ago - Roche announces grand opening of its Innovation Center Boston to drive advancements in Cardiovascular, Renal and Metabolic diseases - GlobeNewsWire
- 2 days ago - Dualitas Therapeutics, Roche Partner On Bispecific Antibody Research - Nasdaq
- 2 days ago - RHHBY Looks 34.1% Overvalued on GF Value™ as Dividend Sustainability Remains Key - GuruFocus